We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Industry

Calbiotech Awarded Contract to Develop Reagents for Dengue Diagnosis

A Small Business Innovative Research Phase I contract by the U.S. Army Medical Research and Material command has been awarded to Calbiotech, which will develop analyte specific reagents for the diagnosis of Dengue virus. More...
24 Nov 2009

Gene Expression Levels Measured in a Variety of Sample Types

A quantitative nuclease protection assay process will be applied microarrays to enable rapid and efficient measuring of gene expression levels in a variety of sample types. More...
12 Nov 2009

Cell Biosciences Completes Acquisition of Alpha Innotech

Cell Biosciences, Inc. has completed its acquisition of Alpha Innotech Corp. The acquisition will significantly expand Cell Biosciences' protein analysis business to include a global infrastructure and a broad protein analysis product portfolio. More...
10 Nov 2009

European Nonprofit to Focus on Personalized Medicine and Diagnostics

A nonprofit launched in Europe will focus on promoting and harmonizing personalized medicine and implementing "high value" diagnostics across the continent. More...
09 Nov 2009

Opportunity Still Exists for Diagnostic Companies in India

Diagnostic companies seeking new growth opportunities in a recessionary economy may want to consider the US$350 million Indian in vitro diagnostics market. More...
28 Oct 2009

Contract for Servicing Diagnostic Systems Extended

Diagnostic systems, including MRI scanners, CT scanners, and ultrasound systems, as well as laboratory systems, surveillance monitors, and anesthesia units will be continuously monitored and serviced for the University of Pennsylvania Health system. More...
27 Oct 2009

IBM Plans to Devise Faster, Less Expensive Sequencing Technology

IBM is in the process of slashing the cost of sequencing a genome, now focused on the US$1,000 mark, jumping into a leading position in the biotech revolution. More...
26 Oct 2009
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Automated Urinalysis Solution
UN-9000
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.